Christoph Brackmann's Insider Trades & SAST Disclosures

Christoph Brackmann's most recent trade in NovoCure Ltd was a trade of 80,674 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2026.

Share

Note

This is a custom search result for pattern Christoph Brackmann.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2026	80,674	80,674	-		-	Stock Option (Right to Buy)
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Mar 2026	55,137	189,254 (0%)	0%		0	Ordinary Shares
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 13.31 per share.	03 Mar 2026	6,412	182,842 (0%)	0%	13.3	85,314	Ordinary Shares
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.23 per share.	04 Nov 2025	7,033	134,117 (0%)	0%	12.2	86,014	Ordinary Shares
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 11.63 per share.	29 Jul 2025	10,000	131,150 (0%)	0%	11.6	116,300	Ordinary Shares
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 11.50 per share.	29 Jul 2025	5,000	141,150 (0%)	0%	11.5	57,500	Ordinary Shares
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 11.60 per share.	29 Jul 2025	5,000	136,150 (0%)	0%	11.6	58,000	Ordinary Shares
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Mar 2025	81,499	81,499	-		-	Stock Options (Right to buy)
NovoCure Ltd	Christoph Brackmann	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 18.19 per share.	04 Mar 2025	54,975	121,150 (0%)	0%	18.2	999,995	Ordinary Shares

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades